These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33451738)

  • 1. Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset.
    Newman NJ; Yu-Wai-Man P; Carelli V; Moster ML; Biousse V; Vignal-Clermont C; Sergott RC; Klopstock T; Sadun AA; Barboni P; DeBusk AA; Girmens JF; Rudolph G; Karanjia R; Taiel M; Blouin L; Smits G; Katz B; Sahel JA;
    Ophthalmology; 2021 May; 128(5):649-660. PubMed ID: 33451738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy.
    Yu-Wai-Man P; Newman NJ; Carelli V; Moster ML; Biousse V; Sadun AA; Klopstock T; Vignal-Clermont C; Sergott RC; Rudolph G; La Morgia C; Karanjia R; Taiel M; Blouin L; Burguière P; Smits G; Chevalier C; Masonson H; Salermo Y; Katz B; Picaud S; Calkins DJ; Sahel JA
    Sci Transl Med; 2020 Dec; 12(573):. PubMed ID: 33298565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A
    Newman NJ; Yu-Wai-Man P; Carelli V; Biousse V; Moster ML; Vignal-Clermont C; Sergott RC; Klopstock T; Sadun AA; Girmens JF; La Morgia C; DeBusk AA; Jurkute N; Priglinger C; Karanjia R; Josse C; Salzmann J; Montestruc F; Roux M; Taiel M; Sahel JA
    Front Neurol; 2021; 12():662838. PubMed ID: 34108929
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy.
    Newman NJ; Yu-Wai-Man P; Subramanian PS; Moster ML; Wang AG; Donahue SP; Leroy BP; Carelli V; Biousse V; Vignal-Clermont C; Sergott RC; Sadun AA; Rebolleda Fernández G; Chwalisz BK; Banik R; Bazin F; Roux M; Cox ED; Taiel M; Sahel JA;
    Brain; 2023 Apr; 146(4):1328-1341. PubMed ID: 36350566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy.
    Yang S; Ma SQ; Wan X; He H; Pei H; Zhao MJ; Chen C; Wang DW; Dong XY; Yuan JJ; Li B
    EBioMedicine; 2016 Aug; 10():258-68. PubMed ID: 27426279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study.
    Biousse V; Newman NJ; Yu-Wai-Man P; Carelli V; Moster ML; Vignal-Clermont C; Klopstock T; Sadun AA; Sergott RC; Hage R; Esposti S; La Morgia C; Priglinger C; Karanja R; Blouin L; Taiel M; Sahel JA;
    J Neuroophthalmol; 2021 Sep; 41(3):309-315. PubMed ID: 34415265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for visual acuity in patients with Leber's hereditary optic neuropathy after rAAV2-ND4 gene therapy.
    Zhang Y; Li X; Yuan J; Tian Z; Liu H; Wang D; Li B
    Clin Exp Ophthalmol; 2019 Aug; 47(6):774-778. PubMed ID: 30968497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Response and Intraocular Inflammation in Patients With Leber Hereditary Optic Neuropathy Treated With Intravitreal Injection of Recombinant Adeno-Associated Virus 2 Carrying the ND4 Gene: A Secondary Analysis of a Phase 1/2 Clinical Trial.
    Bouquet C; Vignal Clermont C; Galy A; Fitoussi S; Blouin L; Munk MR; Valero S; Meunier S; Katz B; Sahel JA; Thomasson N
    JAMA Ophthalmol; 2019 Apr; 137(4):399-406. PubMed ID: 30730541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trial.
    Lam BL; Feuer WJ; Schiffman JC; Porciatti V; Vandenbroucke R; Rosa PR; Gregori G; Guy J
    JAMA Ophthalmol; 2014 Apr; 132(4):428-36. PubMed ID: 24525545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Therapy for Leber Hereditary Optic Neuropathy: Low- and Medium-Dose Visual Results.
    Guy J; Feuer WJ; Davis JL; Porciatti V; Gonzalez PJ; Koilkonda RD; Yuan H; Hauswirth WW; Lam BL
    Ophthalmology; 2017 Nov; 124(11):1621-1634. PubMed ID: 28647203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results.
    Feuer WJ; Schiffman JC; Davis JL; Porciatti V; Gonzalez P; Koilkonda RD; Yuan H; Lalwani A; Lam BL; Guy J
    Ophthalmology; 2016 Mar; 123(3):558-70. PubMed ID: 26606867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-Sectional Analysis of Baseline Visual Parameters in Subjects Recruited Into the RESCUE and REVERSE ND4-LHON Gene Therapy Studies.
    Moster ML; Sergott RC; Newman NJ; Yu-Wai-Man P; Carelli V; Bryan MS; Smits G; Biousse V; Vignal-Clermont C; Klopstock T; Sadun AA; DeBusk AA; Carbonelli M; Hage R; Priglinger S; Karanjia R; Blouin L; Taiel M; Katz B; Sahel JA;
    J Neuroophthalmol; 2021 Sep; 41(3):298-308. PubMed ID: 34310464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leber hereditary optic neuropathy gene therapy.
    Lam BL
    Curr Opin Ophthalmol; 2024 May; 35(3):244-251. PubMed ID: 38117686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial.
    Koilkonda RD; Yu H; Chou TH; Feuer WJ; Ruggeri M; Porciatti V; Tse D; Hauswirth WW; Chiodo V; Boye SL; Lewin AS; Neuringer M; Renner L; Guy J
    JAMA Ophthalmol; 2014 Apr; 132(4):409-20. PubMed ID: 24457989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of rAAV2-ND4 Treatment for Leber's Hereditary Optic Neuropathy.
    Wan X; Pei H; Zhao MJ; Yang S; Hu WK; He H; Ma SQ; Zhang G; Dong XY; Chen C; Wang DW; Li B
    Sci Rep; 2016 Feb; 6():21587. PubMed ID: 26892229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leber Hereditary Optic Neuropathy Gene Therapy: Adverse Events and Visual Acuity Results of All Patient Groups.
    Lam BL; Feuer WJ; Davis JL; Porciatti V; Yu H; Levy RB; Vanner E; Guy J
    Am J Ophthalmol; 2022 Sep; 241():262-271. PubMed ID: 35271811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leber hereditary optic neuropathy gene therapy clinical trial recruitment: year 1.
    Lam BL; Feuer WJ; Abukhalil F; Porciatti V; Hauswirth WW; Guy J
    Arch Ophthalmol; 2010 Sep; 128(9):1129-35. PubMed ID: 20837795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual Acuity Testing Before and After Intravitreal Injection of rAAV2-ND4 in Patients.
    Li B; Wu C
    Methods Mol Biol; 2018; 1715():305-311. PubMed ID: 29188523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of rAAV2/2-ND4 Gene Therapy for Leber Hereditary Optic Neuropathy.
    Vignal C; Uretsky S; Fitoussi S; Galy A; Blouin L; Girmens JF; Bidot S; Thomasson N; Bouquet C; Valero S; Meunier S; Combal JP; Gilly B; Katz B; Sahel JA
    Ophthalmology; 2018 Jun; 125(6):945-947. PubMed ID: 29426586
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural History of Conversion of Leber's Hereditary Optic Neuropathy: A Prospective Case Series.
    Hwang TJ; Karanjia R; Moraes-Filho MN; Gale J; Tran JS; Chu ER; Salomao SR; Berezovsky A; Belfort R; Moraes MN; Sadun F; DeNegri AM; La Morgia C; Barboni P; Ramos CDVF; Chicani CF; Quiros PA; Carelli V; Sadun AA
    Ophthalmology; 2017 Jun; 124(6):843-850. PubMed ID: 28196731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.